OLINK HOLDING AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.32 USD | -0.34% |
|
+1.35% | -7.28% |
| May. 10 | UK Competition Regulator Opens Probe on Thermo Fisher, Olink Merger | MT |
| May. 10 | UK Competition Watchdog Opens Probe on Thermo Fisher Scientific's Acquisition of Olink | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
Financials (USD)
| Sales 2024 * | 206M | Sales 2025 * | 272M | Capitalization | 2.9B |
|---|---|---|---|---|---|
| Net income 2024 * | -18M | Net income 2025 * | 12M | EV / Sales 2024 * | 13.5 x |
| Net cash position 2024 * | 115M | Net cash position 2025 * | 133M | EV / Sales 2025 * | 10.2 x |
| P/E ratio 2024 * |
-152
x | P/E ratio 2025 * |
233
x | Employees | 707 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 15.92% |
More Fundamentals
* Assessed data
More news
Latest transcript on Olink Holding AB
More recommendations
More press releases
More news
| 1 day | -0.34% | ||
| 1 week | +1.35% | ||
| Current month | +1.26% | ||
| 1 month | +0.56% | ||
| 3 months | -3.72% | ||
| 6 months | -6.12% | ||
| Current year | -7.28% |
1 week
22.98
23.50
1 month
21.8023.58
Current year
21.6825.20
1 year
14.1026.01
3 years
8.3938.78
5 years
8.3942.20
10 years
8.3942.20
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 20-11-30 | |
Carl Raimond
PSD | President | 53 | 20-07-31 |
Oskar Hjelm
DFI | Director of Finance/CFO | 39 | 20-02-29 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Nicolas Roelofs
BRD | Director/Board Member | 66 | 17-12-31 |
Jon Hindar
CHM | Chairman | 68 | 20-12-31 |
| Chief Executive Officer | 57 | 20-11-30 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.15% | 5 M€ | -1.80% | - | |
| 0.12% | 0 M€ | 0.00% | - | |
| 0.10% | 0 M€ | +12.11% | ||
| 0.06% | 0 M€ | 0.00% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-10 | 23.32 | -0.34% | 353,117 |
| 24-05-09 | 23.4 | -0.30% | 163,877 |
| 24-05-08 | 23.47 | +1.08% | 176,960 |
| 24-05-07 | 23.22 | +0.30% | 114,342 |
| 24-05-06 | 23.15 | +0.61% | 35,773 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotes
Olink Holding AB (publ) is a Sweden-based company engaged in the marketing and sales of biotechnological products and services. The Company offers a technique to identify actionable biomarkers, with a focus on the human plasma proteome. The Company operates in Sweden and the USA.
Sector
Office Equipment
Calendar
2024-08-06
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
23.32
USD
Average target price
26
USD
Spread / Average Target
+11.49%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -7.28% | 2.9B | |
| +10.45% | 8.23B | |
| -3.84% | 4.66B | |
| +5.67% | 2.14B | |
| -25.01% | 1.15B | |
| -1.50% | 912M | |
| -7.09% | 815M | |
| -22.40% | 764M | |
| -23.70% | 681M | |
| -58.00% | 666M |
- Stock Market
- Equities
- OLK Stock
